Literature DB >> 3287158

Thrombolytic therapy: current status (2).

V J Marder1, S Sherry.   

Abstract

Mesh：

Substances：

Year:  1988        PMID： 3287158     DOI： 10.1056/NEJM198806163182406

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  29 in total

1.  Thrombolytic therapy for acute myocardial infarction. Lessons to be learned.

Authors:  S Sherry
Journal:  Tex Heart Inst J       Date:  1991

2.  Thrombolysis with low dose tissue plasminogen activator.

Authors:  E Doyle; J Britto; J Freeman; F Munro; N S Morton
Journal:  Arch Dis Child       Date:  1992-12       Impact factor: 3.791

3.  Ultrasound-enhanced tissue plasminogen activator thrombolysis in an in vitro porcine clot model.

Authors:  Christy K Holland; Sampada S Vaidya; Saurabh Datta; Constantin-C Coussios; George J Shaw
Journal:  Thromb Res       Date:  2007-09-14       Impact factor: 3.944

4.  Thrombolytic therapy for acute pulmonary embolism.

Authors:  B W Sherman; W F Rutherford
Journal:  West J Med       Date:  1989-07

5.  The effect of the fibrinolytic enzyme FIIa from Agkistrodon acutus venom on acute pulmonary thromboembolism.

Authors:  Xi Lin; Xiu-xia Liang; Jian-jun Tang; Jia-shu Chen; Peng-xin Qiu; Guang-mei Yan
Journal:  Acta Pharmacol Sin       Date:  2011-02       Impact factor: 6.150

Review 6.  Intravenous streptokinase. A reappraisal of its therapeutic use in acute myocardial infarction.

Authors:  K L Goa; J M Henwood; J F Stolz; M S Langley; S P Clissold
Journal:  Drugs       Date:  1990-05       Impact factor: 9.546

7.  Recombinant Tissue Plasminogen Activator in the Treatment of Neonates with Intracardiac and Great Vessels Thrombosis.

Authors:  Milad El-Segaier; Muhammad A Khan; Zaheer Ullah Khan; Tarek Momenah; Mohammed Omar Galal
Journal:  Pediatr Cardiol       Date:  2015-05-21       Impact factor: 1.655

8.  Profiling the immune responses of human patients treated with recombinant streptokinase after myocardial infarct.

Authors:  O Reyes; I Torrens; A G Ojalvo; A Seralena; H E Garay
Journal:  Mol Divers       Date:  2004       Impact factor: 2.943

9.  Tissue plasminogen activator (alteplase) treatment for femoral artery thrombosis after cardiac catheterisation in infants and children.

Authors:  W Zenz; W Muntean; A Beitzke; G Zobel; M Riccabona; A Gamillscheg
Journal:  Br Heart J       Date:  1993-10

10.  Comparison of pharmacokinetics of lanoteplase and alteplase during acute myocardial infarction.

Authors:  John B Kostis; Randy C Dockens; Udho Thadani; Vasnath Bethala; Carl Pepine; Wayne Leimbach; Nimish Vachharajani; Ralph H Raymond; Bruce C Stouffer; Lee K Tay; Wen Chyi Shyu; Wei-chi Liao
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.